America is celebrating 50 years of modern biotechnology advances, ranging from gene editing and immunotherapy to using AI and machine learning in R&D, that continue to reshape the future of medicine. However, nations like China are rapidly ramping up their investments, and U.S. leaders are weighing how to stay competitive, protect critical tech, and continue the pursuit of transformative biotech innovation.
Join Axios Live in D.C. for an event exploring America’s biotech edge and the race for global leadership. We’ll dive into how the latest breakthroughs are helping solve health issues for real people, what factors are affecting the pipeline for discovery, and how policy is shaping future innovation, investment and strategy.
Subscribe to Axios Vitals: Keep up with health care politics, policy and business by Tina Reed and Maya Goldman. With future focused sends by Caitlin Owens.
